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EVIDENCE-BASED ANSWER 
Though clinical preparticipation exams (PPE) are recommended by experts and required in most 
states, we found no medium- or better-quality evidence that demonstrates they reduce mortality or 
morbidity. PPEs detect only a very small percentage of cardiac abnormalities among athletes who 
subsequently die suddenly (strength of recommendation [SOR]: C, case series study). PPEs are 
also unable to accurately identify athletes with exercise-induced bronchospasm (SOR: C, small 
cross-sectional study) and are poorly predictive of which athletes are at increased risk of orthopedic 
injuries (SOR: C, cross-sectional study). 
  EVIDENCE SUMMARY 
A systematic review of the literature on PPE identified 310 studies of athletes age <36 years. The authors 
searched multiple electronic databases and reviewed the bibliographies of retrieved articles but did not perform 
hand searches of journals or contact authors directly. The review did not find any prospective cohort or 
randomized trials addressing the effectiveness of clinical PPE. The 5 studies that assessed the format of the 
PPE concluded that it is not adequately standardized, does not consistently address the American Heart 
Association (AHA) recommendations for cardiovascular screening and exam, and is administered by a variety 
of health care professionals, some without proper training.1 
Sudden cardiac death is defined as a nontraumatic, nonviolent, unexpected event resulting from sudden 
cardiac arrest within 6 hours of a previously witnessed state of normal health.2 Such events occur in about 1 in 
200,000 high school athletes per academic year (about 16 deaths in the US annually). Detection of 
cardiovascular abnormalities that may cause morbidity or mortality is difficult. A case series reviewed 158 
sudden deaths that occurred in trained athletes in the US from 1985 to 1995. The athletes were identified from 
news accounts, the National Center for Catastrophic Sports Injury Registry, and informal communications and 
reports. The authors interviewed families, witnesses, and coaches, and they analyzed postmortem information. 
Of the 115 athletes who had a standard preparticipation medical evaluation, only 4 (3%) were suspected of 
having cardiovascular disease. The cardiovascular abnormality responsible for sudden death was 
prospectively identified in only 1 athlete.3 
PPE does not accurately identify student athletes with exercise-induced bronchospasm (EIB). Of the studies on 
EIB, the best was a prospective cross-sectional study of 352 adolescents from 3 suburban Washington state 
schools. The students completed a 14-item EIB questionnaire, had a physical exam, and underwent a 7-minute 
exercise challenge spirometry. Complete data were available for 256 of the students. EIB was diagnosed by 
spirometry in 9.4% of the athletes. No student had EIB detected solely by physical exam. Using a cutoff of 2 
positive questions, the questionnaire had a sensitivity of 71% and a specificity of 47%, with a negative and 
positive predictive value of 6% and 12%, respectively. This study concluded that EIB occurs frequently in 
adolescent athletes, but screening by physical exam and medical history does not accurately detect it.4 
PPEs are not able to predict which student athletes will experience an orthopedic injury, and no controlled 
studies have been done to determine whether PPE prevents or reduces the severity of orthopedic injuries. A 
study surveyed 1204 student athletes (aged 13–20 years) from Richmond County, Georgia, who had a 
standardized PPE before participating in sports. The questionnaire was administered via mail or telephone and 
inquired about injuries sustained after the PPE. The response rate to the survey was 56%. The study found 
that a history of knee or ankle injury and abnormal findings on exam in male athletes slightly increased the 
likelihood of repeated injury of the same joint. However, the sensitivities of history or physical exam for ankle or 
knee injuries were all <25%.5 
Recommendations from others 
The AHA recommends a national standard for PPE and that screening should be mandatory for all high school 
and college athletes before participation in organized sports, with screening repeated every 2 years, and an 
interim history obtained during the intervening years. Specific items are given in the TABLE.6 
In 2004, the American Academy of Family Physicians, along with the American Academy of Pediatrics, 
American College of Sports Medicine, American Medical Society for Sports Medicine, American Orthopedic 
Society for Sports Medicine, and the American Osteopathic Academy of Sports Medicine, published 
recommendations for PPEs. They suggested a detailed history (consisting of a 16-point questionnaire 
incorporating AHA recommendations for cardiovascular screening), limited medical exam, and a detailed 
musculoskeletal exam evaluating strength, flexibility, and stability of major joints.7 
 
TABLE 
AHA recommendations for preparticipation exams 
CARDIOVASCULAR SCREENING QUESTIONS 
1. Have you ever become dizzy or passed out during or after exercise? 
2. Have you ever had chest pain during or after exercise? 
3. Do you get tired more quickly than your friends do during exercise? 
4. Have you ever had racing of your heart or skipped heartbeats? 
5. Have you ever had high blood pressure or high cholesterol? 
6. Have you ever been told that you have a heart murmur? 
7. Has any family member or relative died of heart problems or sudden death before age 50? 
8. Have you had a severe viral infection such as mononucleosis or myocarditis within the last 
month? 
9. Has a physician ever denied or restricted your participation in sports for any heart problems? 
10. Have any of your relatives ever had any of the following conditions:  
a. Hypertrophic cardiomyopathy 
b. Dilated cardiomyopathy 
c. Marfan’s syndrome 
d. Long QT syndrome 
e. Significant heart arrhythmia 
CARDIOVASCULAR SCREENING EXAM 
1. Recognition of the physical manifestations of Marfan’s Syndrome 
2. Blood pressure, seated position 
3. Palpation of radial and femoral pulses 
4. Cardiac exam to include rate, rhythm and characterization of murmurs and abnormal heart 
sounds.  
a. Precordial auscultation supine 
b. Precordial auscultation standing 
c. Maneuvers to clarify murmurs such as squat-to-stand, deep inspiration, or ValsalvaM 
CARDIAC FINDINGS REQUIRING FURTHER EVALUATION 
1. Murmur grade 3/6 or greater 
2. Diastolic murmur 
3. Murmur that increases with Valsalva or other maneuver 
CLINICAL COMMENTARY 
The PPE provides us an opportunity to address 
preventive health issues 
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Most physicians involved in screening athletes recognize the limitations of PPEs in 
detecting those at risk for sports-related morbidity and mortality. The history is the most 
important part of the examination for identifying athletes who might be at risk and should 
be thorough. Prepared PPE forms such as those endorsed by the AAFP and ACSM can 
assist in obtaining this history. Because this may be the only occasion for the athlete to 
see a physician, the examination is best performed by a primary care provider who can 
use the opportunity to address preventive health issues such as tobacco, alcohol, and 
drug use, depression and suicidality, sexuality, nutrition, and accident prevention. This 
kind of counseling is difficult to do in a group format. 
R E F E R E N C E S  
1. Wingfield  K, Matheson  GO, Meeuwisse  WH. Preparticipation evaluation: an 
evidence-based review.  Clin J Sport Med 2004;14:109–122. 
2. Lyznicki  JM, Nielsen  NH, Schneider  JF. Cardiovascular screening of athletes.  Am 
Fam Physician 2000;62:765–774.  Erratum in: Am Fam Physician, 2001; 63:2332. 
3. Maron  BJ, Shirani  J, Poliac  LC, Mathenge  R, Roberts  WC, Mueller  FO. Sudden 
death in young competitive athletes. Clinical, demographic, and pathological 
profiles.  JAMA 1996;276:199–204. 
4. Hallstrand  TS, Curtis  JR, Koepsell  TD , et al.  Effectiveness of screening 
examinations to detect unrecognized exercise-induced bronchoconstriction.  J 
Pediatr 2002;141:343–348. 
5. DuRant  RH, Pendergrast  RA, Seymore  C, Gaillard  G, Donner  J. Findings from 
the preparticipation athletic examination and athletic injuries.  Am J Dis 
Child 1992;146:85. 
6. Maron  BJ, Thompson  PD, Puffer  JC , et al.  Cardiovascular preparticipation 
screening of competitive athletes. A statement for health professionals from the 
Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects 
Committee (cardiovascular disease in the young), American Heart Association. 
 Circulation 1996;94:850–856. 
7. Smith  DM. American Academy of Family Physicians, Preparticipation Physical 
Evaluation Task Force.  Preparticipation Physical Evaluation.  3rd ed. Minneapolis: 
McGraw-Hill Healthcare; 2004. 
 
